Cain Brothers House Calls Podcast: Communities Benefit from Access to Dental Health

David Johnson is the CEO of 4sight Health, an advisory company working at the intersection of healthcare strategy, economics, innovation. Johnson is a healthcare thought leader, keynote speaker, and strategic advisor to organizations busting the status-quo to reform our healthcare system. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, and his second book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019). As a speaker, Dave plays the role of rebel, challenger, industry historian, investor and company evaluator to push audiences forward. (Watch bio video.) Johnson applies his 25+ years of investment banking in healthcare to identify ways the healthcare industry must change to deliver better care. He received a Masters in Public Policy from Harvard Kennedy School, an English degree from Colgate University, and served in the African Peace Corp service. Join over 10k+ healthcare executives who read our weekly insights and commentary on www.4sighthealth.com. Preorder his third book, The Coming Healthcare Revolution: 10 Forces that Will Cure America’s Health Crisis, now.

Jenny Watson is a Director focused on advising both private and public companies in a variety of M&A, capital raising, valuation, and strategic advisory transactions. Jenny joined Cain Brothers (KeyBanc Capital Markets) in 2014 and has over 12 years of advisory experience.

Her notable transactions include the sale of LIBERTY Dental to WCAS and Anthem, sale of Women’s Health USA to Unified Women’s Health, sale of Children’s Choice Pediatric Dental Care to Amulet Capital, divestiture of Access Dental from Guardian Life Insurance of America to Western Dental, and sale of HealthPro Heritage to Wellspring Capital Management.

She has been involved in transactions in a wide range of healthcare sub-verticals, including provider and payor services, tech enabled services, HCIT, medtech and diagnostics, and her experience includes public and private company advisory, corporate divestitures, strategic alternatives, and fairness opinions / valuations.